HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Top Retailers Driving Chemical Policy Adherence With ‘Clean Beauty’ Seals

Executive Summary

What exactly is “clean beauty”? At Target and Sephora, it means phasing out many traditional preservatives, among other commonly used but “unwanted” ingredients, and getting prominent placement and the retailers’ “Clean” stamps of approval in return.

You may also be interested in...



Sephora Well-Positioned To Defend ‘Clean Beauty’ Case, Attorney Says

Sephora USA is in a strong position to defend its ‘Clean at Sephora’ designation for certain products because it is transparent about what the claim means, and the plaintiff in the case may not be able to show that a reasonable consumer would be misled, says Angela Diesch, partner in the Los Angeles office of Amin Talati Wasserman, LLP.

CTPA Takes Stand Against ‘Free From’ Claims, Urges Focus On Cosmetics’ ‘Positive Attributes’

In a position paper published on 6 October, the UK cosmetics trade group says “free from” claims can sow confusion among consumers, damage trust in brands and the industry, and lead to safe and effective ingredients no longer being used. In many instances, “free from” claims also may violate UK and EU law, according to CTPA.

Sephora At Kohl’s Lineup Released: ‘Some Of The Most Relevant And Exciting Brands In The Industry’

The curated assortment of prestige beauty brands, tended by trained beauty advisors, will launch in 200 Kohl’s stores across the US, as well as Kohls.com, in August.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel